Notice bibliographique
Résumé
London Health Sciences Centre-University Campus, London, Ontario, Canada. michael.sharpe@lhsc.on.caCardiac Drug Therapy, 6th Edition. By M. Gabriel Khan. Philadelphia, WB Saunders, 2003. Pages: 542. ISBN: 0721602428. Price: $44.95.If your practice involves any patient receiving therapy for ischemic or valvular heart disease, hypertension, arrhythmias, congestive heart failure, or hyperlipidemia or receiving antiplatelet/anticoagulation therapy, then M.G. Khan’s 6th edition of Cardiac Drug Therapy is a must buy for your reference library. In other words, this complete and up-to-date reference text should be of interest to every practicing clinician. This new edition includes significant new information compared with the last edition, including evidence from numerous randomized clinical trials that have been published in this area during the last 4 yr.I highly recommend first reading the preface to the sixth edition, which is a good introduction to Khan’s entertaining style of writing and also sets the tone for the following content. Khan combines his obvious wealth of clinical experience with the succinct conclusions of pertinent randomized clinical trials to formulate his recommendations/guidelines of cardiac therapy. In particular, the book is careful to distinguish between conclusions and recommendations based on firm scientific evidence and those based on experience and theoretical considerations. Although preferring the former approach, he also does not unduly disparage the latter. However, when appropriate, he does not hesitate to reveal and discredit treatment dogmas that have been applied to clinical practice, often for years, without any scientific basis.I suspect this text will be an exception to the usual reference text that spends most of its life sitting on the shelf, utilized occasionally for a quick reference. For example, I approached the review of this text intending only to sample its content. However, I found that I actually read the majority of the book, which for me is quite unusual for a reference text. This is probably because of Khan’s unique literary style that links inherently boring pharmacological information with current evidence and applies this directly to the experience and practice of cardiac care. The presentation is complete yet succinct, allowing a considerable amount of useful information to be consolidated into a very concise format.I was particularly impressed with the last chapter of the text, which is a compilation of the results (in the form of charts that are very easy to read) of the most recent clinical trials pertaining to therapy for acute coronary syndrome, heart failure, hypertension, and arrhythmias. The results of these trials are also dispersed throughout the text as they pertain to current therapy guidelines and are referenced to this chapter. The text also includes the most recent Advanced Cardiac Life Support algorithms as well as chapters discussing cardiac drugs in pregnancy and a discussion of interactions of cardiovascular drugs.In sum, this text is an excellent review of state-of-the-art cardiac therapy. It is therefore a useful reference for any individual who cares for patients with cardiac disease and should not be reserved solely for the cardiologist or internist. Medical students and residents will find it of particular value during their patient care rotations.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,001 | 0,004 |
| Méta-épidémiologie (sens strict) | 0,002 | 0,001 |
| Méta-épidémiologie (sens large) | 0,002 | 0,001 |
| Bibliométrie | 0,003 | 0,002 |
| Études des sciences et des technologies | 0,001 | 0,001 |
| Communication savante | 0,004 | 0,002 |
| Science ouverte | 0,002 | 0,002 |
| Intégrité de la recherche | 0,002 | 0,004 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,277 | 0,279 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».